Oxford Nanopore Technologies: Revolutionizing oncology with comprehensive multiomic sequencing solutions

Join Oxford Nanopore Technologies to explore how real-time, direct DNA sequencing is transforming oncology and clinical research. The session will feature two pioneering applications of nanopore technology in oncology. Areeba Patel will discuss rapid, comprehensive molecular profiling of CNS tumors using methylation-based nanopore sequencing, showcasing its potential for clinical implementation. Francisco Marchi will present the Acute Leukemia Methylome Atlas, built from over 3,000 leukemia samples, demonstrating how long read nanopore sequencing and machine learning can predict AML subtypes and patient outcomes with remarkable accuracy. Together, these talks highlight how nanopore sequencing is redefining precision oncology with speed, flexibility, and multiomic depth.